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Table A-1 Compounds proposed for suspect screening analysis














Amoxicillin	C16H19N3O5S	366.1118	114.0018	 ADDIN EN.CITE [, ]
Amphetamine	C9H13N	136.1121	91.0542	 ADDIN EN.CITE [, ]
Aripiprazole	C23H27Cl2N3O2	448.1553	285.0899	[]
Aspirin	C9H8O4	181.0495	137.0245	 ADDIN EN.CITE [, ]
Atomoxetine	C17H21NO	256.1696	117.0715	[]
Atorvastatin	C33H35FN2O5	559.2603	440.2232	[]

























































Estradiol	C18H24O2	273.1849	145.0660	 ADDIN EN.CITE [, ]













Furosemide	C12H11ClN2O5S	331.0150	81.0194	 ADDIN EN.CITE [, ]





Hydrochlorothiazide	C7H8ClN3O4S2	297.9718	268.9463	 ADDIN EN.CITE [, ]

















Lidocaine	C14H22N2O	235.1805	86.0965	 ADDIN EN.CITE [, ]
Lincomycin	C18H34N2O6S	407.2210	126.1268	[]








































































































































Table A-2 Protocols of optimization for fat and lipid retention
Procedure: 1 g of fish in falcon 15 mL. Addition of 2 mL of H2O 0.1 mL F.A. and 8 mL of MeOH. Shake manually. Vortexed 1 min. USE 15 min. Centrifugation 4000 rpm, 12 min at 3ºC. Extraction of 6 mL of supernatant. Addition of alumina. Shake manually. Vortexed 1 min. Centrifugation 4000 for 6 min 3ºC. Extraction of 2.5 mL of supernatant. Evaporation to dryness in testing tube previously weighted. Calculate % of fat retained in the alumina.














Table A-3 Protocols of pharmaceuticals retention in filters
Procedure: 0.5 mL of NH4OAC: MeCN 90:10. Spiked with 25 ng mL-1 of mix standard solution. Filtered. 




































































Tabla A-4. Protocols of optimization of extraction of PhACs in fish. 
Protocol	Fish weight (g)	Spike (ng of PhAC)	Solvents (mL)	Extraction method	Clean up	Coments:
1	1.0	100	H2O (9) / MeCN (10) / F.A. (0.1)	QuEChERS citrate-kit-01 (4g MgSO4, 1 g NaCL, 1 g NaCitrate, 0.5 g disodium citrate sesquihydrate)	6 mL supernatant. Clean-up sorbents: 400 mg PSA, 400 mg C18, 1200 mg MgSO4.	Final extract: 5 mL. Freezing overnight. Extraction 1 mL. Evaporation to dryness and reconstitution to 1mL NH4OH 5mM:MeCN 90:10.
2	0.5	25	MeCN:IPrOH:F.A 3:1:0.1% (1.0)	10 min USE	Freezing overnight. Centrifugation 14000 rpm, 10 min, 0ºC. Extraction supernatant	Final extract: 0.5 mL.2 glass beads (0.4 mm Ø) for better interaction matrix solvent.Direct injection without reconstitution
3	0.5	25	MeCN:IPrOH:F.A 3:1:0.1% (1.0)	10 min USE	Freezing overnight. Centrifugation 14000 rpm, 10 min, 0ºC. Extraction 0.8 mL supernatant	Final extract: 0.8 mL.2 glass beads (0.4 mm Ø) for better interaction matrix solvent.Evaporation to dryness and reconstitution to 0.8mL NH4OH 5mM: MeCN 90:10. 
4	1.0	50	MeCN:IPrOH:F.A 3:1:0.1% (5.0)	10 min USE	Freezing overnight. Centrifugation 14000 rpm, 10 min, 0ºC. Extraction 0.8 mL supernatant	Final extract: 2.5 mL.2 glass beads (0.4 mm Ø) for better interaction matrix solvent.Evaporation to dryness and reconstitution to 1.0 mL NH4OH 5mM: MeCN 90:10. 
5	1.0	50	H2O 0.05% F.A:MeCN 90:10 (5.0)	10 min USE	Centrifugation 14000 rpm, 10 min, 0ºC. Extraction 1.0 mL supernatant	Final extract: 1.0 mL. 




Table A-5 Recoveries of PhACs during optimization of extraction (Table A-4).



































































Table A-6 recovery of pharmaceuticals in fish at 3 validated levels. 
	Recovery A (RSD) (%)
Compound	5 ng/ g fish	25 ng/ g fish	50 ng/ g fish
Acetaminophena	77 (13)	48 (6)	82 (2)
Acridoneb	78 (5)	91 (3)	79 (7)
Atenololc	87 (10)	90 (7)	84 (6)
Bezafibrated	75 (9)	85 (10)	82 (7)
Bromazepamb	92 (10)	77 (5)	72 (10)
Caffeinee	139 (4)	99 (6)	103 (8)
Carazololf	100 (15)	97 (3)	85 (20)
Carbamazepineb	101 (5)	85 (4)	84 (5)
Chlorpromazineg	100 (3)	97 (2)	81 (4)
Clarithromycinh	75 (8)	81 (5)	79 (19)
Codeinec	131 (5)	86 (7)	104 (10)
Diazepamh	82 (6)	94 (2)	85 (11)
Diltiazemb	120 (6)	100 (3)	81 (23)
Erythromycing	130 (3)	152 (8)	123 (13)
Fenofibratei	159 (19)	153 (8)	196 (8)
Flumequineb	52 (5)	57 (4)	50 (12)
Fluoxetineh	109 (7)	113 (9)	81 (15)
Furazolidonej	88 (2)	102 (9)	86 (9)
Ketaminej	88 (8)	80 (1)	63 (10)
Ketoprofenh	79 (15)	92 (4)	80 (2)
Lamotriginek	89 (21)	77 (19)	61 (18)
Loratadined	100 (14)	113 (12)	99 (19)
Lorazepamg	99 (11)	101 (3)	82 (3)
Mefenamic acidd	96 (16)	111 (4)	95 (12)
Mephedronee	71 (14)	79 (3)	57 (17)
Methadoneg	92 (7)	104 (14)	82 (20)
Metoprololl	40 (48)	89 (11)	82 (10)
Midazolamb	90 (8)	94 (3)	72 (15)
Nalidixic acidf	49  (2)	51 (7)	44 (12)
Oxazepamb	89 (8)	98 (3)	82 (3)
Oxcarbazepineb	93 (8)	117 (6)	95 (3)
Propyphenazoneb	120 (5)	94 (3)	84 (10)
Salbutamolc	98 (3)	50 (1)	51 (21)
Sertralineh	82 (4)	78 (3)	70 (4)
Sotalolc	79 (2)	65 (6)	62 (7)
Sulfadimethoxinef	108 (18)	125 (4)	94 (6)
Sulfamethazinej	135 (4)	172 (4)	107 (1)
Sulfamethoxazolef	106 (2)	101 (8)	101 (9)
Sulfapyridinee	99 (7)	104 (5)	91 (2)
Temazepamh	89 (5)	100 (4)	87 (5)
Trimethoprime	113 (15)	76 (2)	62 (14)
Valsartan acidf	63 (10)	62 (21)	41 (4)
Valsartand	74 (18)	79 (14)	86 (3)
Venlafaxinef	63 (17)	93 (5)	76 (3)
Verapamilh	60 (4)	86 (4)	80 (9)
Warfarind	113 (6)	104 (1)	93 (12)
Zolpidemf	122 (6)	107 (5)	84 (12)
A. Recovery calculated as the percentage of the relation between the area of the pharmaceutical`s peak spiked in fish and the area of the pharmaceutical`s peak spiked in extracted matrix.
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